NCT06274151View on ClinicalTrials.gov

Optimal Treatment of Acute Skeletal Muscle Injury

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2029

Conditions
Muscle Strain, Multiple SitesInflammation
Interventions
DRUG

Naproxen 500 Mg

Attenuating the sub-acute inflammatory processes to monitor potential beneficial tissue healing following a muscle strain injury

PROCEDURE

Rehabilitation

Rehabilitation after muscle strain injury

DRUG

Placebo

Sub-acute inflammatory processes not attenuated. Group will be treated as control to monitor tissue healing following a muscle strain injury without pharmacological intervention.

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT06274151 - Optimal Treatment of Acute Skeletal Muscle Injury | Biotech Hunter | Biotech Hunter